MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data
Young,Attractive,Female,Scientist,Holding,A,Red,Transparent,Pill,With

Webinar

Unique Advantages of Incorporating Untargeted and Targeted Metabolomics in Drug Development and Clinical Trials

Biomarkers increase the success rate of drug development. Indeed, biomarker-driven drug development can de-risk multimillion-dollar decisions about the mechanism of action, safety, dosage, timing, patient response, and other factors critical to your molecule’s success. Yet, traditional biomarker discovery tools—genomics, transcriptomics, and proteomics — stop short of a definitive representation of the clinical phenotype. The addition of metabolomics provides a functional readout of all upstream biological processes as well as environmental factors (e.g., microbiome), increasing confidence in your decisions and the success rate of drug development. 

Watch our on-demand webinar as experts discuss the use and benefits of incorporating untargeted and targeted metabolomics into the drug development process. How will an understanding of related pathways and the underlying physiology help you?

Learn how metabolomics can enable biomarker-driven drug development and clinical trials by providing:

  • better understanding of a drug’s mechanism of action (MoA)
  • greater confidence in human translational models
  • insights into off-target effects and target engagement
  • identification of unique therapy responders versus non-responders in clinical trials
  • highly customized targeted assays to monitor clinical response
Register & Watch
Back to Resource Library
  • Lipid Profiles and Heart Failure Risk: Results From Two Prospective Studies
    Previous ProjectLipid Profiles and Heart Failure Risk: Results From Two Prospective Studies
  • Next ProjectDried Blood Spot (DBS) Card Analysis on Metabolon’s Precision Metabolomics™ Platform
    Lipid Profiles and Heart Failure Risk: Results From Two Prospective Studies

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Quality Assurance
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events
  • Publications

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

in
Copy